| ID | Name | CAS | Data |
Tfus (K) |
| 102-700-0 |
6-hydroxy-4,4-dioxo-6,7-dihydro-5H-thieno[4,5-b]thiopyran-2-sulfonamide
|
|
4 | 483.53 |
| 105-147-2 |
N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine
|
|
4 | 392.22 |
| 105-982-5 |
4-hydroxy-5,6-dihydro-4H-thieno[5,4-b]thiopyran-2-sulfonamide
|
|
4 | 457.12 |
| 105-983-4 |
4-oxo-5,6-dihydrothieno[5,4-b]thiopyran-2-sulfonamide
|
|
4 | 458.54 |
| 105-985-2 |
4,7,7-trioxo-5,6-dihydrothieno[5,4-b]thiopyran-2-sulfonamide
|
|
4 | 515.65 |
| 108-236-0 |
(5-methyl-2-propan-2-ylpyrazol-3-yl) N,N-dimethylcarbamate
|
|
4 | 347.30 |
| 108-388-2 |
4-amino-1-[4-fluoro-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
|
|
4 | 461.80 |
| 109-006-4 |
5-(benzoyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
|
|
4 | 433.65 |
| 110-372-6 |
8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido[2,3-d]pyrimidine-6-carboxylic acid
|
|
4 | 522.81 |
| 110-527-4 |
3-(3,5-Dichlorophenyl)-1,5-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione
|
|
4 | 437.87 |
| 111-443-6 |
5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
|
|
4 | 594.34 |
| 111-573-2 |
5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
|
|
4 | 584.86 |
| 112-131-1 |
4-hydroxy-7,7-dioxo-5,6-dihydro-4H-thieno[5,4-b]thiopyran-2-sulfonamide
|
|
4 | 440.65 |
| 114-678-3 |
Silane, [[(15«alpha»,16«alpha»,17«beta»)-estra-1,3,5(10)-triene-3,15,16,17-tetrayl]tetrakis(oxy)]tetrakis[trimethyl-
|
57305-24-5 |
4 | 362.88 |
| 114-700-7 |
6«beta»-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, anti
|
|
4 | 384.24 |
| 114-736-8 |
Danazol (2,4-Pregnadien-(2,3-d)isoxazol-17A-ethynyl-17B-ol), TMS
|
|
4 | 416.48 |
| 115-630-4 |
1,3,5(10)-Oestratriene-3,17«alpha»-diol, 3-TBDMS-17-PFP
|
|
4 | 384.64 |
| 116-159-7 |
3H-1,4-benzodiazepine-2,5-dione,4-(p-chlorophenyl)-1,2,4,5-tetrahydro-1-methyl-
|
1036-16-4 |
4 | 427.49 |
| 116-236-1 |
1H-Pyrazolo[4,3-d]pyrimidine, 7-amino-3-«beta»-D-ribofuranosyl-
|
6742-12-7 |
4 | 528.65 |
| 116-338-8 |
Quinazolinone, 4(3h)-, 3-(3-chloro-o-tolyl)-2-methyl-
|
1915-77-1 |
4 | 435.12 |
| 116-507-0 |
3H-1,4-benzodiazepine-2,5-dione, 7-chloro-1,2,4,5-tetrahydro-1,4-dimethyl-
|
|
4 | 404.63 |
| 116-579-1 |
2,3,17-Tris[(trimethylsilyl)oxy]estra-1,3,5(10)-triene, (17«beta»)-
|
51497-42-8 |
4 | 377.51 |
| 117-411-5 |
Cholan-24-oic acid, 3,7-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester, (3«alpha»,5«beta»,7«alpha»)-
|
55320-14-4 |
4 | 373.59 |
| 117-425-0 |
N-(P-AMINOPHENYLSULFONYL)-N-(3,4-DIMETHYL-5-ISOXAZOLYL)ACETAMIDE
|
|
4 | 466.65 |
| 117-886-9 |
Phosphorothioic acid, O,O-dimethyl O-[3-methyl-4-(methylsulfonyl)phenyl] ester
|
3761-42-0 |
4 | 327.52 |
| 118-785-0 |
N-acetyl-n-(p-aminobenzene-sulfonyl)-2-amino-4,6-dimethylpyrimidine
|
|
4 | 463.38 |
| 119-116-1 |
20«alpha»-hydroxy-pregn-4-en-3-one, MO-TMS, syn
|
|
4 | 378.38 |
| 119-307-9 |
Pregnane-3,20-dione, 21-[(trimethylsilyl)oxy]-, bis(O-methyloxime), (5«alpha»)-
|
57305-26-7 |
4 | 374.40 |
| 119-503-1 |
6«beta»-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, syn
|
|
4 | 384.24 |
| 119-750-7 |
Silane, [[(3«beta»,17«beta»)-androst-5-ene-3,17-diyl]bis(oxy)]bis[dimethyl-2-propenyl-
|
66250-82-6 |
4 | 337.73 |
| 119-992-9 |
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(trimethylsilyl)-
|
62374-32-7 |
4 | 462.56 |
| 120-552-5 |
Pregn-4-ene-3,20-dione, 11-hydroxy-17,21-bis[(trimethylsilyl)oxy]-, bis(O-methyloxime), (11«beta»)-
|
57305-44-9 |
4 | 403.25 |
| 120-855-9 |
6«alpha»-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, syn
|
|
4 | 384.24 |
| 120-920-6 |
2,2-Dichloropropanoic acid compound with n,n-dimethylamine (1:1)
|
|
4 | 380.90 |
| 121-822-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-
|
|
4 | 593.77 |
| 122-219-3 |
3-Hydroxy-4-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 364.30 |
| 122-879-1 |
Trimethylsilyl 4-(2-aminophenyl)-4-oxo-2-[(trimethylsilyl)amino]butanoate
|
|
4 | 351.13 |
| 123-526-1 |
5-Pregnene-3«beta»,20«beta»,21-triol, methylboronate-TMS
|
|
4 | 382.63 |
| 123-652-1 |
3H-1,4-benzodiazepine-2,5-dione, 8-chloro-1,2,4,5-tetrahydro-1,4-dimethyl-
|
1018-73-1 |
4 | 404.69 |
| 123-693-6 |
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-3-[(trimethylsilyl)oxy]-
|
35147-95-6 |
4 | 389.17 |
| 123-962-7 |
Silane, [[(3«beta»,17«beta»)-androst-5-ene-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
42151-22-4 |
4 | 378.70 |
| 124-812-2 |
Ketone, 5-amino-4-nitro-2-thienyl-3,4-dichlorophenyl
|
|
4 | 485.39 |
| 11-734-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, TMS
|
|
3 | 360.81 |
| 12-155-6 |
3,3-Dimethyl-1-(4-phenylphenoxy)-1-(1,2,4-triazol-1-yl)butan-2-ol, trimethylsilyl ether
|
|
3 | 380.94 |
| 13-180-7 |
5«alpha»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 363.33 |
| 13-232-9 |
tert-Butyldimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 362.85 |
| 13-482-2 |
3.alpha.,5.beta.-dihydroxy-5.beta.-cholan-24-oic acid, TMS
|
|
3 | 362.57 |
| 13-641-5 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«alpha»,5«beta»)-
|
65598-73-4 |
3 | 405.34 |
| 13-690-1 |
5-Cholenoic acid, 3-«beta»,12-«alpha»-dihydroxy, methyl ester, TMS
|
|
3 | 365.22 |
| 13-761-2 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one-O-methyloxime, triimethylsilyl
|
|
3 | 380.14 |
| 13-818-9 |
5«beta»-cholestane, 3«alpha»,7«beta»,12«alpha»-trihydroxy, TMS
|
|
3 | 353.42 |
| 14-269-8 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi
|
|
3 | 421.39 |
| 14-306-6 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi, (20-O)-TMSi
|
|
3 | 381.62 |
| 14-864-7 |
Silane, [(3«beta»)-cholesta-5,7-dien-3-yloxy]trimethyl-
|
2625-44-7 |
3 | 357.69 |
| 15-373-1 |
1H-Naphtho[2,1-b]pyran-1-one, 3-phenyl-
|
6051-87-2 |
3 | 441.85 |
| 16-439-7 |
allo-Cholanic acid, 3«alpha»,7«alpha»-dihydroxy, Me-DMES
|
|
3 | 368.17 |
| 16-756-5 |
5«beta»-Homocholane-3«alpha»,7«alpha»,25-triol, TMS
|
|
3 | 363.13 |
| 17-014-7 |
epi-5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 361.90 |
| 18-481-8 |
Benzeneacetic acid, «alpha»-hydroxy-«alpha»-phenyl-, 1-methyl-3-piperidinyl ester
|
3321-80-0 |
3 | 365.86 |
| 19-562-7 |
1,3,5(10)-Oestratriene-2,3,17.beta.-triol, 2,3-TMS-17-HFB
|
|
3 | 388.46 |
| 19-671-6 |
1,3,5(10)-Oestratriene-2-methoxy-3,17«beta»-diol, 3-TBDMS-17-HFB
|
|
3 | 389.26 |
| 21-300-4 |
Phosphoric acid, 2-(diethylamino)-6-methyl-4-pyrimidinyl diethyl ester
|
|
3 | 288.45 |
| 22-124-9 |
1,1'-Bis[n-methyl-n-(4-nitrophenyl)-carboxamido] ferrocene
|
|
3 | 459.46 |
| 25-289-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»-ol (stigmastanol), DMESI
|
|
3 | 352.33 |
| 26-737-5 |
5«alpha»-Pregnane-3«alpha»,20«alpha»,21-triol, TMS
|
|
3 | 363.02 |
| 28-380-9 |
5-«alpha»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 396.41 |
| 28-753-5 |
5-«alpha»-Pregnan-3-«alpha»-16-«alpha»-diol-20-one, TMS
|
|
3 | 394.41 |
| 29-886-7 |
5-«beta»-Cholestan-3-«beta»,7-«alpha»,12-«alpha»-triol, TMS
|
|
3 | 353.42 |
| 31-960-1 |
2-(2,4-Dichlorophenyl)-1-(1,2,4-triazol-1-yl)hexan-2-ol, trimethylsilyl ether
|
|
3 | 310.68 |
| 32-527-1 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol, bis(trimethylsilyl) ether
|
10426-36-5 |
3 | 363.33 |
| 34-872-6 |
Methyl 5-«beta»-cholan-3-«beta»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 378.17 |
| 35-400-8 |
5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 368.19 |
| 35-938-2 |
5«alpha»-Pregnane-3«beta», 20«beta», 21-triol, MO TMS
|
|
3 | 363.02 |
| 36-250-4 |
epi-5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 368.19 |
| 36-761-7 |
5-Pregnen-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS
|
|
3 | 406.20 |
| 37-683-3 |
5-«beta»-Pregnan-3-«alpha»-ol-20-one, MO-TMS
|
|
3 | 380.14 |
| 38-365-5 |
5-(3-Dimethylaminopropyl)-10,11-dihydro-5h-dibenz-[b,f]-azepine, hydrochloride
|
|
3 | 445.10 |
| 38-420-3 |
Silane, [(3,7,11,15-tetramethyl-2-hexadecenyl)oxy]trimethyl-
|
57397-39-4 |
3 | 217.54 |
| 38-562-6 |
Androstane, 3,17-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»,17«alpha»)-
|
10426-35-4 |
3 | 363.33 |
| 38-861-4 |
5-«alpha»-Pregnan-3-«beta»-16-«alpha»-diol-20-one, TMS
|
|
3 | 394.41 |
| 39-634-5 |
5-«alpha»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 378.57 |
| 39-730-8 |
5-«beta»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 378.57 |
| 41-865-6 |
5-«alpha»-Pregnan-3-«beta»,20-«alpha»,21-triol, TMS
|
|
3 | 363.02 |
| 42-635-0 |
5«beta»-Pregnane-3«beta»-ol-20-one, MO TMS
|
|
3 | 380.14 |
| 43-713-2 |
Methyl 5-«beta»-cholan-3-«alpha»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 378.17 |
| 44-687-1 |
Phenothiazine, 2-chloro-10-(3-dimethylaminopropyl)-, cmpd with o-(p-hydroxybenzoyl)benzoic acid (1 to 1)
|
|
3 | 521.95 |
| 44-863-5 |
Silane, [(3.beta.,5.alpha.)-cholest-7-en-3-yloxy]trimethyl-
|
|
3 | 363.55 |
| 45-247-8 |
Silane, trimethyl[[(3«beta»,5«alpha»)-stigmastan-3-yl]oxy]-
|
55493-85-1 |
3 | 361.90 |
| 46-896-7 |
5-«alpha»-Pregnan-3-«beta»,15 or 16-diol-20-one, MeTMS
|
|
3 | 394.41 |
| 47-555-4 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | 363.33 |
| 50-920-4 |
Ergosta-5,7,9(11),22-tetraen-3«beta»-ol, TMS
|
|
3 | 393.63 |
| 51-206-6 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»,21-triol, MeTMS
|
|
3 | 363.02 |
| 51-590-0 |
1-Cyclopentadienyl-5-phenyl-1,1,3,3,5,5-hexamethyl trisiloxane
|
|
3 | 273.55 |
| 51-610-7 |
5-Cholesten-3-«beta»,7-«alpha»,25,26-tetrol, TMS
|
|
3 | 353.70 |
| 53-221-7 |
2-Chloro-10-(3'-dimethylaminopropyl)-5,5-phenothiazinedioxide, hydrochloride, monohydrate
|
|
3 | 494.97 |
| 53-684-4 |
5-«alpha»-Pregnan-3-«beta»-15x-diol-20-one, TMS
|
|
3 | 386.05 |
| 56-112-5 |
5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 361.90 |
| 56-883-0 |
3-.beta.,7-.alpha.-Dihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
3 | 388.14 |
| 57-634-5 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, DMESI
|
|
3 | 341.50 |
| 57-713-7 |
Trimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 340.23 |
|
« Previous Results
Next Results »
|